Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Chronic Disease

5,8,11,14-eicosatetraynoic acid has been researched along with Chronic Disease in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Page Thomas, DP1
Phillips, NC1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Chronic Disease

ArticleYear
Intra-articular liposomal therapy.
    Frontiers of biology, 1979, Volume: 48

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthrit

1979